Introduction {#s1}
============

Identifying and characterizing biomarkers that accurately reflect a physiological state (normal or diseased) or response to a particular drug or therapy is challenging. High-quality biomarkers are especially important for cancer detection and the development of safe, effective treatments. Such biomarkers are also the ultimate goal of many next-generation sequencing studies ([@B40]; [@B1]).

Many methods for analyzing differential expression in RNA sequencing (RNA-seq) data with the aim of finding genes that are differentially expressed across groups of samples have been established, such as *t*-test, limma ([@B11]), edger ([@B26]), and DEseq2 ([@B20]). However, these methods tend to consider only the linear relationship (differential expression) between gene expression and phenotype, but may overlook nonlinear relationships (as shown in [**Figure 1**](#f1){ref-type="fig"}) because gene expression may differ between population groups or indeed between individuals, and can also vary as a patient's status changes. As shown in [**Figure 1**](#f1){ref-type="fig"}, both high and low levels of *IGLC1* gene expression are found in non-tumor samples. The *IGLC1* gene would thus generally be overlooked in cancer studies, with it giving a large *p*-value in the *t*-test (0.48). However, the expression of this gene is actually very useful to discriminate between control subjects and patients affected by prostate cancer.

![Nonlinearly expressed pattern of the *IGLC1* gene for prostate tumor from microarray data ([@B29]). Both high and low levels of *IGLC1* gene expression are found in non-tumor samples.](fgene-10-01410-g001){#f1}

The maximal information coefficient (MIC) was proposed to capture a wide range of associations of two variables, in both linear and nonlinear relationships ([@B25]). Owing to its generality, MIC is becoming widely accepted in scientific research ([@B41]), and is also used to analyze large biological datasets ([@B24]; [@B38]; [@B39]). However, even with MIC, it is difficult to identify genes with a nonlinear expression pattern as the genes giving the most strongly supported hits are linearly expressed. This makes MIC less practical for the exploration of nonlinear informative genes in next-generation sequencing datasets such as those obtained by RNA-seq.

We developed a novel nonlinearity measure, normalized differential correlation (NDC), which could efficiently find nonlinearly expressed genes in RNA-seq datasets. We verified its validity on six real-world, publicly available cancer RNA-seq datasets (for details on the datasets, see [**Table 1**](#T1){ref-type="table"}). The results showed that it could discover most genes that were nonlinearly expressed across groups of samples, even though these genes could not be identified by popular differential expression analysis approaches. We also validated these genes using classification performance, gene function analysis, and survival analysis. As expected, the results confirmed that the expression of these genes is related to the phenotype.

###### 

Six binary-class RNA-seq datasets.

  Cancer types                          No. of patients   No. of gene
  ------------------------------------- ----------------- -------------
  Breast Cancer (BRCA)                  114               20,530
  Kidney Clear Cell Carcinoma (KIRC)    72                20,530
  Liver Cancer (LIHC)                   50                20,530
  Lung Adenocarcinoma (LUAD)            58                20,530
  Lung Cancer (LUNG)                    109               20,530
  Lung Squamous Cell Carcinoma (LUSC)   51                20,530

Datasets and Methods {#s2}
====================

Datasets {#s2_1}
--------

The details of the six gene expression RNA-seq datasets are summarized in [**Table 1**](#T1){ref-type="table"}. Level 3 data of TCGA were downloaded from the UCSC Xena platform ([@B12]). For each dataset, the patient samples do not contain paracarcinoma tissue were excluded.

Methods {#s2_2}
-------

MIC can capture dependence between pairs of variables, including both functional and nonfunctional relationships. However, the ApproxMaxMI method provided by [@B25] results in a larger MIC score for paired variables under finite-sample conditions ([@B5]). Here, we use the improved algorithm ChiMIC to calculate the MIC value ([@B5]). The NDC score for a pair of data series *x* (gene) and *y* (phenotype) is defined as follows:
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Here, *R* ^2^ (*x*,*y*) and \|*R*(*x*,*y*)\| are the determination coefficient and absolute value of the correlation coefficient, respectively. For a discrete phenotype, *R* ^2^(*x*,*y*) and *R*(*x*,y) are effective only for a binary class. *Thre~MIC~*, the confidence limit at level *p* = 0.05 based on a given sample size, can be calculated as follows:

Step 1: Expression data of one gene (*x~i~*) are selected at random from the expression matrix and the sample order is shuffled;

Step 2: The MIC value between initial categorization labels (normal or diseased) and shuffled expression data is calculated;

Step 3: This process is repeated 1,000 times or more and these MIC values are sorted in ascending order. The MIC value at the 95% fractile is denoted as *Thre~MIC~*.

The NDC score is the normalized difference between nonlinear measure (MIC) and linear measure (*R* ^2^) by \|R\|. Because the MIC value is suspected of being large under finite-sample conditions, we use *MIC*(*x*,*y*)-*Thre~MIC~* to rule this out. We use the nonlinear score ("*MIC*(*x*,*y*)-*Thre~MIC~*") minus the linear score (*R* ^2^) to exclude the linearly expressed genes. Lastly, we use *R*(*x*,*y*) as the background normalized to exclude the genes that are irrelevant to the categorization labels. Therefore, a higher NDC score indicates a strong nonlinear association, but a weak linear correlation.

In [**Figures 2A--D**](#f2){ref-type="fig"}, the genes are ranked by the NDC score, as well as the corresponding result in [**Figure 3**](#f3){ref-type="fig"}. In other results, we first rank the genes in descending order of NDC score; then, we further sort the 1,000 most highly ranked genes in descending order by MIC value to obtain the most important nonlinear genes (top genes).

![Comparison of gene ranking by *t*-test, edgeR, DEseq2, maximal information coefficient (MIC), and normalized differential correlation (NDC) for the lung squamous cell carcinoma (LUSC) dataset. In **(A--F)**: the color indicating data density; The red and black circles are just approximate region to visualize that, there are some genes can be highlighted by DNC methods, but cannot be highlighted by t-test. **(G)** overlaps of the top 100 genes selected by five methods.](fgene-10-01410-g002){#f2}

![Comparison of genes selected by *t*-test, edgeR, DEseq2, maximal information coefficient (MIC), and normalized differential correlation (NDC) on five other datasets. **(A)** BRCA, **(B)** KIRC, **(C)** LIHC, **(D)** LUAD, **(E)** LUNG.](fgene-10-01410-g003){#f3}

Results and Discussion {#s3}
======================

Identification of Nonlinearly Expressed Informative Genes {#s3_1}
---------------------------------------------------------

Four popular differential expression analysis methods, namely, *t*-test, edgeR, DEseq2, and MIC, were selected here for comparison with the NDC measure. We took the typical linear method, *t*-test, as a benchmark. [**Figures 2A--F**](#f2){ref-type="fig"} illustrate and compare the rank of each gene between the *t*-test and the other methods for lung squamous cell carcinoma (LUSC). As shown in [**Figure 2C**](#f2){ref-type="fig"}, most of the top genes highlighted by MIC are linearly expressed. There are also some genes (red circled area) that can be detected by MIC but not by *t*-test, edgeR, and DEseq2; these can be defined as nonlinearly expressed genes. However, these nonlinearly expressed genes cannot be identified as important by MIC as it confers a low ranking on them. As indicated in [**Figures 2D--F**](#f2){ref-type="fig"}, only the NDC measure can efficiently identify the importance of these nonlinearly expressed genes (such as the black circled area). We also used the rank correlation coefficient to quantify the results by different methods, as shown in [**Table 2**](#T2){ref-type="table"}. [**Figure 2G**](#f2){ref-type="fig"} illustrates the overlaps of the top 100 genes selected by five methods. There are many overlaps among the top 100 genes selected by the *t*-test, edgeR, DEseq2, and MIC methods, but no overlap between the NDC measure and the other methods. The same results were also obtained for five other datasets ([**Figure 3**](#f3){ref-type="fig"}). We therefore deduce that the NDC measure is able to identify important nonlinearly expressed genes, while the other four reference methods could only discover linearly expressed ones.

###### 

Rank correlation coefficient among five methods.

  Methods   t-test      EdgeR       DESeq2      MIC
  --------- ----------- ----------- ----------- -------
  EdgeR     0.763                               
  DESeq2    0.778       0.967                   
  MIC       0.870       0.654       0.668       
  NDC       **0.080**   **0.033**   **0.045**   0.494

[**Figure 4**](#f4){ref-type="fig"} illustrates the top gene highlighted by the NDC measure for each dataset. The expression patterns of these genes are clearly the same as in [**Figure 1**](#f1){ref-type="fig"}. From a data-driven perspective, these genes have high power to discriminate between the two classes. However, they achieve a low ranking with the reference methods. For example, with regard to PSAT1 for BRCA ([**Figure 4A**](#f4){ref-type="fig"}), the rankings by *t*-test, DESeq2, edgeR, and MIC are 8,583rd, 4,642nd, 4,292nd, and 947th, respectively. The details of the rankings by the reference methods for the top genes highlighted by NDC are shown in [**Table 3**](#T3){ref-type="table"}.

![Expression pattern of top gene highlighted by the normalized differential correlation (NDC) measure for each dataset. **(A)** BRCA, **(B)** KIRC, **(C)** LIHC, **(D)** LUAD, **(E)** LUNG, **(F)** LUSC.](fgene-10-01410-g004){#f4}

###### 

The ranking order by reference methods for the top gene of six datasets highlighted by normalized differential correlation (NDC).

  Gene symbol   t-test   edgeR   DEseq2   MIC
  ------------- -------- ------- -------- -------
  PSAT1         8,583    4,642   4,292    947
  CCDC146       10,504   4,738   5,525    1,081
  MANEAL        8,983    6,521   7,713    216
  GJB1          13,072   6,049   5,969    1,336
  EFS           11,207   7,742   8,559    957
  SCN9A         13,660   9,275   7,842    1,091

Besides the expression patterns shown in [**Figure 4**](#f4){ref-type="fig"}, another pattern was identified in KIRC, as shown in [**Figure 5**](#f5){ref-type="fig"}. We found that the expression level of ERAP2 was stratified into four levels. Essentially, ERAP2 is a differentially expressed gene here, with 27 out of 72 patients having lower ERAP2 expression levels. ERAP2 is a proteolytic enzyme that acts in the endoplasmic reticulum, where it plays a central role in the trimming of peptides for presentation by MHC class I molecules (MHC I) ([@B28]; [@B27]). [@B9] reported that MHC I and ERAP2 are under the control of NF-κB through enhancer A in human neuroblastoma cells. [@B10] also found that ERAP2 interacts with epithelial cell adhesion molecule (EpCAM) in breast cancer cells; EpCAM is a well-known epithelial and cancer cell "marker" ([@B33]; [@B30]; [@B2]). These patients in this study were also divided into two groups regarding their expression levels of ERAP2; this indicated that the expression of ERAP2 was strongly associated with the tumor grade (p-value of chi-squared test of 0.0084). Those in the group with high expression of ERAP2 have poorly differentiated KIRC ([**Table 4**](#T4){ref-type="table"}). All of this evidence suggests that ERAP2 may play a regulatory role in cancer. However, only the NDC method was able to identify the importance of ERAP2 (ranking: 14th); in contrast, all of the reference methods failed to identify the importance of this gene, with the rankings by *t*-test, DESeq2, edger, and MIC being 10,567th, 4,819th, 4,382, and 2,561th, respectively.

![Expression pattern of ERAP2 in KIRC. Tumor samples and paracarcinoma tissue samples from the same patient are connected by a black line.](fgene-10-01410-g005){#f5}

###### 

Contingency table for expression of ERAP2 and tumor grade in KIRC.

             Low expression   High expression
  ---------- ---------------- -----------------
  G1 or G2   16               10
  G3 or G4   10               29

G1: well differentiated, G2: moderately differentiated, G3: poorly differentiated, G4: undifferentiated. Seven patients (TCGA-B8-5552, TCGA-CJ-5679, TCGA-CJ-5680, TCGA-CJ-5681, TCGA-CW-5591, TCGA-CZ-5456, TCGA-CZ-5469) are excluded due to inconsistent expression patterns.

Classification Accuracy {#s3_2}
-----------------------

To measure the impact of the nonlinearly expressed genes selected by NDC on the classification, we examined the classification accuracy on the six datasets with a supported vector classifier (SVC). SVC was performed using LIBSVM ([@B4]), which is available at <http://www.csie.ntu.edu.tw/~cjlin/libsvm/index.html>. Rigorous 10-fold cross-validation was used to evaluate the performance of the various gene selection algorithms. The dataset was randomly divided into 10 subsets. For each run, 9 out of 10 subsets were selected to be the training set and the remaining samples were used as test samples. For a fair comparison between gene selection algorithms, the training and test sets for each run were kept the same for all algorithms. In this section, in contrast to the case in the other sections, we could obtain 10 gene subsets for each method on each dataset.

[**Figure 6**](#f6){ref-type="fig"} illustrates the 10-fold cross-validation prediction accuracy using the top 10, 20, 30, 40, and 50 genes selected by NDC, as well as by *t*-test, edgeR, DEseq2, and MIC. The results reveal comparable accuracy for the five methods. This indicates that analysis of these nonlinearly expressed genes has sufficient ability to distinguish samples from cancerous tissue and from paracarcinoma tissue, *via* a machine learning approach.

![Prediction accuracy of five methods on six datasets based on supported vector classifier (SVC). **(A)** BRCA, **(B)** KIRC, **(C)** LIHC, **(D)** LUAD, **(E)** LUNG, **(F)** LUSC.](fgene-10-01410-g006){#f6}

Biological Interpretation of the Nonlinearly Expressed Genes {#s3_3}
------------------------------------------------------------

### Enrichment Analysis of Pathways and Biological Processes {#s3_3_1}

We further validated these top 100 genes selected by five methods using the LUSC dataset as an example, according to Metascape (A Gene Annotation & Analysis Resource) ([@B42]), as shown in [**Figure 7**](#f7){ref-type="fig"}. We found that these nonlinearly expressed genes selected by NDC ([**Figure 7E**](#f7){ref-type="fig"}) were enriched in the ten terms, and these terms have no overlap between other terms enriched by reference methods. However, for the glutathione conjugation term, [@B8] reported that glutathione-S-transferases (GSTs) catalyze the conjugation of glutathione with toxic oxidant compounds and were associated with acute and chronic inflammatory lung diseases. For the glycerophospholipid metabolism term, phosphoenolpyruvate carboxykinase (PEPCK) has been shown to promote cancer cell survival under conditions of nutrient deprivation, a typical feature in solid cancers, as well as cancer growth ([@B21]; [@B17]; [@B23]; [@B35]). Recently, [@B18] further showed that mitochondrial PEPCK (PEPCK-M) mediates the synthesis of glycerol phosphate from noncarbohydrate precursors, and that PEPCKM is needed to maintain the levels of glycerophospholipids, major constituents of biomembranes, in starved lung cancer cells.

![Enrichment analyses of pathways and biological processes by top 100 genes selected by five methods for lung squamous cell carcinoma (LUSC) dataset. **(A)** *t*-test, **(B)** edgeR, **(C)** DEseq2, **(D)** maximal information coefficient (MIC), **(E)** normalized differential correlation (NDC).](fgene-10-01410-g007){#f7}

### Gene Module Analysis {#s3_3_2}

We further identified four co-expressed gene modules (as shown in [**Figure 8**](#f8){ref-type="fig"}) by weighted gene coexpression network analysis (WGCNA) ([@B16]) for the top 100 nonlinearly expressed genes in the LUSC dataset. For the hub gene SCN9A (Aliases: Nav1.7), which was also selected as the top gene by the NDC method. [@B3] found that the inhibition of Na~v~1.7 activity or expression could reduce H460 non-small cell lung carcinoma (NSCLC) cell invasion by up to 50%; this indicated that functional expression of the subunit Na~v~1.7 promotes the invasion of H460 NSCLC cells. For the hub gene PPL, the corresponding protein was reported to interact with AKT1 protein ([@B34]; [@B36]), suggesting its possible role as a localization signal in AKT1-mediated signaling. Notably, many studies have shown that aberrant Akt activation is associated with the development of many tumors ([@B31]; [@B15]). Both [@B6] and [@B19] reported that p-Akt overexpression can be used as an indicator of poor prognosis in NSCLC.

![Weighted gene coexpression network analysis (WGCNA) for the top 100 nonlinearly expressed genes in the lung squamous cell carcinoma (LUSC) dataset. Power is set to 5 and the threshold of TOM is set to 0.05.](fgene-10-01410-g008){#f8}

### Survival Analysis {#s3_3_3}

For the nonlinearly expressed genes, as shown in [**Figure 9A**](#f9){ref-type="fig"}, the patients were divided into two groups depending on their expression pattern. In the case of the PPL gene in the LUSC dataset, it showed higher expression in tumor tissue for 26 patients and in paracarcinoma tissue for 25 patients. We further compared the overall survival of the two groups of patients, with the results indicating that some nonlinearly expressed genes were strongly associated with overall survival, such as PPL (hub gene for WGCNA), SCN9A (hub gene for WGCNA and the first ranked gene for NDC), EPS8 (second ranked gene for NDC), and MTAP (fourth ranked gene for NDC) for the LUSC dataset. As shown in [**Figures 9B--E**](#f9){ref-type="fig"}, patients with the high expression of PPL in tumor tissue compared with the level in paracarcinoma tissue had significantly shorter overall survival (p = 0.033). SCN9A and EPS8 were the top 2 ranked genes selected by the NDC method, exhibiting similar patterns of expression (as shown in [**Figure 8**](#f8){ref-type="fig"}). The expression of SCN9A was not significantly associated with overall survival (p = 0.113), but that of EPS8 was p = 0.038. It has been reported that EPS8 is strongly associated with tumor progression and metastasis ([@B37]; [@B22]; [@B14]; [@B7]). Furthermore, we found that PPL, SCN9A, and EPS8 are functionally related, as shown in [**Figure 9F**](#f9){ref-type="fig"}. EPS8 is a crucial molecule that mediates EGFR-induced activation of Akt ([@B13]) and PPL proteins as a localization signal in AKT1-mediated signaling by interacting with AKT1 ([@B34]; [@B36]). Akt activation is well known to be associated with the development of many tumors ([@B31]; [@B15]), and it can also prevent FoxO3a, a tumor suppressor, from binding to EPS8. Moreover, it was reported that EGFR, *via* a U0126-sensitive ERK1/2 pathway, controls the transcriptional upregulation of SCN9A to promote cellular invasion in NSCLC cell lines ([@B3]). MTAP, a tumor suppressor gene, has been reported to be associated with the overall survival of NSCLC patients, which is consistent with our results (p = 0.04) ([@B32]). Furthermore, the expression pattern of MTAP is strongly correlated with the vital status of LUSC patients (p = 0.002). A total of 28 out of 36 patients with the high expression of MTAP in tumor tissue compared with the level in paracarcinoma tissue died, but only 4 out of 15 with a low MTAP expression level in tumor tissue did so.

![Survival analysis of PPL, SCN9A, EPS8, and MTAP for the lung squamous cell carcinoma (LUSC) dataset. **(A)** Expression pattern of PPL in LUSC. Tumor samples and paracarcinoma tissue samples from the same patient are connected by a black line. **(B--E)** Results of survival analysis for PPL, SCN9A, EPS8, and MTAP. **(F)** Functional network for PPL, SCN9A, and EPS8.](fgene-10-01410-g009){#f9}

Conclusion {#s4}
==========

In this paper, we propose a novel nonlinearity measure named NDC to efficiently identify nonlinearly expressed genes in transcriptome datasets. Validation using six real-world cancer datasets revealed that the NDC method could identify nonlinearly expressed genes that were overlooked by *t*-test, MIC, edgeR, and DEseq2, although MIC could capture nonlinear correlations. The results regarding the classification accuracy indicate that these genes have sufficient ability to distinguish cancer and paracarcinoma tissue samples. Moreover, the results of biological interpretation of these genes also suggest that some of them are involved in key functional pathways associated with cancer progression and metastasis. All of this evidence suggests that these nonlinearly expressed genes may play central roles in regulating cancer progression. Interestingly, as shown in [**Figures 4**](#f4){ref-type="fig"} and [**5**](#f5){ref-type="fig"}, analysis of these nonlinearly expressed genes proved that genes could be expressed in different patterns in different patients. This explains the need for the development of precision medicine, but also the challenges associated with this. Not all of the top-ranked nonlinearly expressed genes or hub genes found here have previously been reported to correlate with cancer progression and metastasis, but the NDC method suggests their importance as informative genes. The approach presented here suggests that these genes warrant attention as potential targets for therapy and disease risk predictors, as well as for their ability to achieve a clinical diagnosis and evaluate therapeutic efficacy.
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